Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Potential treatment option for severe emphysema under study

Potential treatment option for severe emphysema under study

September 25, 2008

Emory University researchers are participating in a nationwide study to explore an investigational treatment for advanced widespread emphysema. The EASE (Exhale Airway Stents for Emphysema) Trial focuses on airway bypass, a minimally invasive procedure designed to reduce excessive lung inflation and shortness of breath - typical complications of emphysema - by making new pathways for trapped air to exit the lungs.

During the airway bypass procedure, new openings are created in the airway wall connecting the damaged lung tissue to the natural airway. These pathways are supported and kept open by several new drug-eluting stents.




"Emphysema permanently destroys lung function and there are currently limited treatment options for people with this devastating disease," says Rabih Bechara, MD, assistant professor and director of interventional pulmonology, Emory University School of Medicine. "This is an exciting study that could offer substantial relief to participants, and eventually possibly to the millions who suffer from the effects of emphysema."

Emphysema, usually caused by chronic tobacco smoking, is a persistent, progressive and irreversible lung disease characterized by shortness of breath and the destruction of lung tissue. Over time, the tiny air sacs in the lungs, or alveoli, are damaged and lose their elasticity.

This loss of the lungs' natural elasticity and the collapse of airways in the lung combine to make exhalation ineffective, leaving emphysema sufferers with hyperinflation because they are unable to get air out of their lungs. Breathing becomes inefficient and patients have to work very hard to breathe - making normal activities, such as walking, eating or even bathing, difficult. There is no cure and few treatment options are available for most patients.

"By creating new pathways for airflow with the airway bypass procedure, we hope to reduce hyperinflation and improve lung function," says Bechara, principal investigator of the study at Emory. "Currently, patients are often in poor physical condition, struggling with each breath so if we can help patients breathe easier it is likely to improve their quality of life."

Physicians commonly use bronchoscopes to examine the airways within the lungs. Participants in the trial are randomized two to one to an airway bypass or a control group. If randomized to the airway bypass group, physicians will first use a Doppler probe inserted through the bronchoscope to identify a site in the airway that is away from blood vessels. A special needle is then used to make a small opening and the stent is placed in the passageway to keep it open. The procedure involves placing up to six Exhale® Drug-Eluting Stents - manufactured by Broncus Technologies, Inc.

Although this procedure is still under clinical investigation, feasibility data suggest it may hold promise for patients with emphysema. Results from the open-label Exhale Drug-Eluting Stent feasibility study were published in the October 2007 issue of the Journal of Thoracic and Cardiovascular Surgery. Positive results included a statistically significant reduction in the amount of air trapped in the lungs and an improvement in breathing for patients at six months after the airway bypass procedure.

Emory University



Related Emphysema Current Events and Emphysema News Articles Emphysema Current Events and Emphysema News RSS Emphysema Current Events and Emphysema News RSS
UCSF Fresno leading-edge study lends hope to emphysema patients
Patients in the Valley with emphysema might soon be breathing a little easier thanks to a new airway bypass study called the Exhale Airways Stents for Emphysema (EASE) trial.

Wildfires Cause Ozone Pollution to Violate Health Standards, New Study Shows
Wildfires can boost ozone pollution to levels that violate U.S. health standards, a new study concludes.

Red wine may lower lung cancer risk
Moderate consumption of red wine may decrease the risk of lung cancer in men, according to a report in the October issue of Cancer Epidemiology, Biomarkers & Prevention¸ a journal of the American Association for Cancer Research.

Common bronchodilator linked to increased deaths
A common bronchodilator drug which has been used for more than a decade by patients with chronic obstructive pulmonary disease (COPD) has been linked to a one-third higher risk of cardiovascular-related deaths.

COPD? Eat your veggies
You know it's good for you in other ways, but could eating your broccoli also help patients with chronic lung disease? It just might.

Key component of debilitating lung disease identified
For the first time, researchers have demonstrated a close correlation between the decline in a key component of the lung's antioxidant defense system and the progression of chronic obstructive pulmonary disease (COPD) in humans.

Creating lung cancer risk models for specific populations refines prediction
Lung cancer risk prediction models are enhanced by taking into account risk factors by race and by measuring DNA repair capacity, according to research teams led by epidemiologists at The University of Texas M. D. Anderson Cancer Center in two complementary papers appearing in the September issue of Cancer Prevention Research.

Low level cadmium exposure linked to lung disease
New research suggests that cadmium is one of the critical ingredients causing emphysema, and even low-level exposure attained through second-hand smoke and other means may also increase the chance of developing lung disease.

Yale study shows why cigarette smoke makes flu, other viral infections worse
A new study by researchers at Yale School of Medicine could explain why the cold and flu virus symptoms that are often mild and transient in non-smokers can seriously sicken smokers. Published in the Journal of Clinical Investigation, the study also identified the mechanism by which viruses and cigarette smoke interact to increase lung inflammation and damage.

Genetic mutation associated with increased risk of lung cancer
Carriers of a common genetic disorder previously linked to lung disease may have a 70-percent to 100-percent increased risk of lung cancer, according to a report in the May 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
More Emphysema Current Events and Emphysema News Articles


Natural Therapies for Emphysema and COPD: Relief and Healing for Chronic Pulmonary Disorders
by Robert J. Green Jr.

The first book to address emphysema and chronic obstructive pulmonary disease (COPD) from a nutritional and alternative medicine approach • Explains the benefits of detoxification, dietary changes, and food combining • Details 45 suggested herbs and 26 nutritional supplements as well as information on how to stop smoking Approximately 35 million people in the United States have been diagnosed...



Breathe Out: Living Life to the Fullest, with Emphysema, COPD, or Smoker's Lung
by Mary Callahan RN

BREATHE OUT THROUGH PURSED LIPS! Those words are golden for persons with chronic lung disease. Once mastered, the technique can help with everything from going up stairs to picking up a grandchild, all without shortness of breath. That advice and so many more practical tips for getting through the day and getting through life are contained in the pages of this book. Understanding how...



The Quiet Killer: Emphysema/Chronic Obstructive Pulmonary Disease
by Thomas L. Petty

This work covers emphysema and Chronic Obstructive Pulmonary Disease (COPD), offering new hope and insight for sufferers and their loved ones. COPD/emphysema, the fourth most common cause of death, is America's most rapidly growing health problem, claiming approximately 110,000 lives each year. Although much has been done to improve the length and the quality of life in people with...



The Chronic Bronchitis and Emphysema Handbook
by François Haas, Sheila Sperber Haas

"Dr. François Haas is an unusually gifted scientist and a compassionate human being."–HOWARD A. RUSK, M.D. Founder and Chairman, Rusk Institute The bestselling guide for chronic bronchitis and emphysema sufferers–newly revised and expanded. For the millions of people diagnosed with chronic bronchitis and/or emphysema, this bestselling guide is now revised and expanded to offer the most...

Pulmonary Emphysema
by Alvan L Barach



Breathing Free: The Revolutionary 5-Day Program to Heal Asthma, Emphysema, Bronchitis, and Other Respiratory Ailments
by Teresa Hale

MAKE THE BREATH CONNECTION -- AND SAVE YOUR OWN LIFEAre you one of the hundreds of thousands of Americans who suffer from asthma, emphysema, bronchitis, or other respiratory ailments? Far too often, people with these illnesses are prescribed medications that only mask symptoms, instead of really treating the underlying condition. If you are among this group, it's time for you to escape this...



Living a Healthy Life With Chronic Conditions: Self-Management of Heart Disease, Arthritis, Stroke, Diabetes, Asthma, Bronchitis, Emphysema & Others
by Halsted, M.D. Holman, David, M.D. Sobel, Virginia Gonzalez



Lung Volume Reduction Surgery for Emphysema (Lung Biology in Health and Disease)

Collects all available knowledge on the subject, featuring the latest data on the national emphysema treatment trial. Explores the epidemiology of emphysema, the management of complications, and surgical controversies in lung volume reduction surgery for emphysema...

Pathology of chronic bronchitis and emphysema;
by Brian Edyvean Heard



Molecular Biology of the Lung: Emphysema and Infection (Respiratory Pharmacology and Pharmacotherapy)

The techniques and knowledge in molecular biology are advancing rapidly. The basic mechanisms involved in the pathogenesis of various lung conditions including asthma, COPD and lung cancer are being clarified by the application of this powerful technology. Genetic causes of single gene disorders such as cystic fibrosis and -1 antitrypsin deficiency have now been well delineated. This progress...

© 2008 BrightSurf.com